French 2019 Budget A Mix Of Good And Bad News For Pharma
Executive Summary
The French government is proposing to extend the use of the temporary use authorization system for unapproved drugs and to increase the rate of generic prescribing. It has also set a low threshold for the increase in pharmaceutical sales that triggers the payback mechanism.
You may also be interested in...
French Industry Welcomes Moves To Speed Up Access To Innovative Drugs
A French government/industry discussion forum has come up with concrete plans for accelerating access to innovative medicines by streamlining clinical trial approval and price negotiations.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.